» Articles » PMID: 39794756

β-Glucan Induced Plasma B Cells Differentiation to Enhance Antitumor Immune Responses by Dectin-1

Overview
Journal BMC Immunol
Publisher Biomed Central
Date 2025 Jan 10
PMID 39794756
Authors
Affiliations
Soon will be listed here.
Abstract

Background: B lymphocytes, essential in cellular immunity as antigen-presenting cells and in humoral immunity as major effector cells, play a crucial role in the antitumor response. Our previous work has shown β-glucan enhanced immunoglobulins (Ig) secretion. But the specific mechanisms of B-cell activation with β-glucan are poorly understood. Here, we took advantage of β-glucan to improve the antitumor immune response of B cells.

Results: In vitro experiments demonstrate that β-glucan enhance the differentiation of B220 CD138 B cells, up-regulate co-stimulatory molecules, and increase the production of cytokines and Ig in response to various antigens. Using the Dectin-1 knockout mice, we revealed that β-glucan modulate B cell immune responses dependent on Dectin-1 receptor. In mouse models of Lewis lung cancer (LLC) tumors, combining β-glucan with programmed death-1(PD-1) blocking antibodies led to increase recruitment of CD19 B cells in the tumor microenvironment (TME), higher numbers of germinal centers B cells (GC B) in the spleen and draining lymph node (DLN), elevate Ig production, and delay tumor progression.

Conclusions: These findings reveal that β-glucan can serve as a potent adjuvant to modulate B cell immune responses in a Dectin-1 dependent manner and improve immune checkpoint blockade (ICB) therapy in antitumor.

Clinical Trial Number: Not applicable.

References
1.
Wang Z, Zhang H, Liu R, Qian T, Liu J, Huang E . Peyer's patches-derived CD11b B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium-induced colitis. Immunology. 2018; 155(3):356-366. PMC: 6187209. DOI: 10.1111/imm.12977. View

2.
Gunderson A, Rajamanickam V, Bui C, Bernard B, Pucilowska J, Ballesteros-Merino C . Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Oncoimmunology. 2021; 10(1):1900635. PMC: 7993148. DOI: 10.1080/2162402X.2021.1900635. View

3.
Tangye S, Nguyen T, Deenick E, Bryant V, Ma C . Inborn errors of human B cell development, differentiation, and function. J Exp Med. 2023; 220(7). PMC: 10242086. DOI: 10.1084/jem.20221105. View

4.
Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R . B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020; 577(7791):549-555. PMC: 8762581. DOI: 10.1038/s41586-019-1922-8. View

5.
Zografou C, Vakrakou A, Stathopoulos P . Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders. Front Immunol. 2021; 12:686466. PMC: 8248361. DOI: 10.3389/fimmu.2021.686466. View